- Merck wins FDA approval for subcutaneous Keytruda (MRK:NYSE) Seeking Alpha
- FDA OKs New Keytruda Shot for Cancer The New York Times
- EMA committee recommends approval for injectable version of Merck’s Keytruda Reuters
- Merck wins approval of subcutaneous Keytruda, in bid to extend life of world’s top-selling drug Endpoints News
- FDA Approves Subcutaneous Pembrolizumab for Solid Tumors OncLive
Source link
